Brochure | April 23, 2026

Cell & Gene Therapy Clinical Development Testing

Source: Eurofins
cell-gene-therapy-GettyImages-2157300524

Eurofins Clinical Trial Solutions delivers end-to-end analytical and bioanalytical support designed to advance cell and gene therapy programs from early development through late-phase clinical trials. With deep expertise across molecular biology, virology, immunology, and biomarker science, the team supports complex modalities with tailored strategies that address both scientific and regulatory challenges.

Leveraging advanced technology platforms — ranging from PCR and cell-based assays to next-generation sequencing — and a globally integrated laboratory network, Eurofins ensures consistent, high-quality data generation across regions and study phases. This coordinated approach enables faster turnaround times, seamless study execution, and data packages that are robust, reproducible, and aligned with evolving global regulatory expectations.

By combining scientific depth with operational scale, Eurofins Clinical Trial Solutions helps sponsors make confident, data-driven decisions, reduce development risk, and accelerate the path from discovery to clinical impact.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA